Impact of Sorbs2 dysfunction on cardiovascular diseases
Xiaowei Xiong1, Hon-Chi Lee1, Tong Lu1
1The Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, United States of America.
Insights
Cardiovascular diseases (CVDs) are a leading cause of death. This review explores how Sorbin and SH3 domain-containing protein 2 (Sorbs2) dysfunction may contribute to CVD development, highlighting genetic factors.
Area of Science:
- Cardiovascular science and genetics.
- Molecular biology and disease mechanisms.
Background:
- Cardiovascular diseases (CVDs) are the primary global cause of mortality.
- Genetic factors significantly influence CVDs, yet their precise roles are not fully understood.
- Sorbin and SH3 domain-containing protein 2 (Sorbs2) is present in cardiovascular tissues and its malfunction is implicated in CVDs.
Purpose of the Study:
- To review the current knowledge on the role of Sorbs2 in cardiovascular disease.
- To elucidate the potential mechanisms by which Sorbs2 dysregulation contributes to CVD development.
Main Methods:
- Literature review of studies investigating Sorbin and SH3 domain-containing protein 2 (Sorbs2).
- Analysis of existing evidence on Sorbs2 expression, function, and its association with cardiovascular pathologies.
- Synthesis of data on genetic and molecular pathways involving Sorbs2 in cardiovascular disease.
Main Results:
- Sorbs2 is expressed in the cardiovascular system and plays a role in cellular functions relevant to heart health.
- Evidence suggests a link between Sorbs2 genetic variations or altered expression and the pathogenesis of various CVDs.
- Dysregulation of Sorbs2 impacts pathways crucial for cardiac structure and function.
Conclusions:
- Sorbs2 is an emerging factor in cardiovascular disease etiology.
- Further research into Sorbs2 mechanisms is crucial for understanding and potentially treating CVDs.
- Targeting Sorbs2 pathways may offer novel therapeutic strategies for cardiovascular conditions.
Abstract:
Despite significant advancements in prevention and treatment over the past decades, cardiovascular diseases (CVDs) remain the leading cause of death worldwide. CVDs involve multifactorial inheritance, but our understanding of the genetic impact on these diseases is still incomplete. Sorbin and SH3 domain-containing protein 2 (Sorbs2) is ubiquitously expressed in various tissues, including the cardiovascular system. Increasing evidence suggests that Sorbs2 malfunction contributes to CVDs. This manuscript will review our current understanding of the potential mechanisms underlying Sorbs2 dysregulation in the development of CVDs.
More Related Videos
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Overview of the Vascular System
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...


